UY25951A1 - PURIFIED TUMOR NECROSIS FACTOR RECEPTOR POLYPEPTIDES (TYPE II) - Google Patents
PURIFIED TUMOR NECROSIS FACTOR RECEPTOR POLYPEPTIDES (TYPE II)Info
- Publication number
- UY25951A1 UY25951A1 UY25951A UY25951A UY25951A1 UY 25951 A1 UY25951 A1 UY 25951A1 UY 25951 A UY25951 A UY 25951A UY 25951 A UY25951 A UY 25951A UY 25951 A1 UY25951 A1 UY 25951A1
- Authority
- UY
- Uruguay
- Prior art keywords
- protein
- seq
- amino acids
- amino acid
- acid sequence
- Prior art date
Links
Abstract
Una composición que consiste esencialmente en una proteína que comprende una secuencia de aminoácidos seleccionados del grupo de aminoácidos 1- 163 de SEQ ID NO:2 y los aminoácidos 1-233 de SEQ ID NO:4, en donde dicha proteína puede unirse a TNF. Una composición farmacéutica que incluya una proteina, y un diluyente o vehiculo aceptables desde el punto de vista farmacéutico. Una proteina libre de proteinas no especificas que comprende una secuencia de aminoacidos seleccionados del grupo que consiste en los aminácidos 1-163 de SEQ ID NO:2 y los aminoacidos 1-233 de SEQ ID NO:4, donde dicha proteina puede unirse a TNF. Una proteina aislada y purificada que comprende un polipéptido identico a un polipéptido que tiene una secuencia de aminoacidos que comprende los aminoacidos 1-163 de SEQ ID NO:2, o idéntica a un polipéptido que tiene una secuencia de aminoácidos que comprende los aminoacidos 1-233 de SEQ ID NO:4, con la excepción de una o más modificaciones de la secuencia de aminoácidos selecionados del grupo que consiste en: 1- inactivación de sitios de glicosilación de enlace N; 2- modificación de puntos de ruptura de proteasa KEX2; y 3- sustituición o supresión de residuos de cisteina, donde dicha protiena puede unirse puede a TNF.A composition consisting essentially of a protein comprising an amino acid sequence selected from amino acid group 1- 163 of SEQ ID NO: 2 and amino acids 1-233 of SEQ ID NO: 4, wherein said protein can bind TNF. A pharmaceutical composition including a protein, and a pharmaceutically acceptable diluent or carrier. A protein free of non-specific proteins comprising a sequence of amino acids selected from the group consisting of amino acids 1-163 of SEQ ID NO: 2 and amino acids 1-233 of SEQ ID NO: 4, where said protein can bind TNF . An isolated and purified protein comprising a polypeptide identical to a polypeptide having an amino acid sequence comprising amino acids 1-163 of SEQ ID NO: 2, or identical to a polypeptide having an amino acid sequence comprising amino acids 1- 233 of SEQ ID NO: 4, with the exception of one or more amino acid sequence modifications selected from the group consisting of: 1- inactivation of N-link glycosylation sites; 2- modification of KEX2 protease breakpoints; and 3- substitution or deletion of cysteine residues, where said protein can bind to TNF.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
UY25951A UY25951A1 (en) | 2000-01-17 | 2000-01-17 | PURIFIED TUMOR NECROSIS FACTOR RECEPTOR POLYPEPTIDES (TYPE II) |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
UY25951A UY25951A1 (en) | 2000-01-17 | 2000-01-17 | PURIFIED TUMOR NECROSIS FACTOR RECEPTOR POLYPEPTIDES (TYPE II) |
Publications (1)
Publication Number | Publication Date |
---|---|
UY25951A1 true UY25951A1 (en) | 2001-08-27 |
Family
ID=38812147
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UY25951A UY25951A1 (en) | 2000-01-17 | 2000-01-17 | PURIFIED TUMOR NECROSIS FACTOR RECEPTOR POLYPEPTIDES (TYPE II) |
Country Status (1)
Country | Link |
---|---|
UY (1) | UY25951A1 (en) |
-
2000
- 2000-01-17 UY UY25951A patent/UY25951A1/en not_active Application Discontinuation
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Carlsen et al. | Human chorionic gonadotropin: linear amino acid sequence of the β subunit | |
PL372849A1 (en) | Use of transthyretin peptide/protein fusions to increase the serum half-life of pharmacologically active peptides/proteins | |
KR850004273A (en) | Recombinant gamma interferon with increased stability and preparation method thereof | |
ECSP064643A (en) | GLP-1 FUSION PROTEINS | |
AR065349A1 (en) | GLUCAGON / GLP-1 RECEIVER COAGONISTS | |
EE05111B1 (en) | Interferon beta-fusion proteins and their use | |
CY1105616T1 (en) | PEPTIDE INHIBITORS OF TGFβ1 | |
AR062867A2 (en) | INTERLEUQUINE LINK PROTEINS -18, (IL-18BP), DNA SEQUENCES CODING FOR IL -18 BP, cDNA SEQUENCES, A REPLICABLE EXPRESSION VEHICLE, GUEST CELL, A PROCESS FOR PRODUCTION AND INSULATION, ANTIBODIES, COMPOUNDS, COMPOUNDS PHARMACEUTICS, THE USE OF SUCH COMPOSITIONS FOR THE | |
BR9913698A (en) | Enterotoxin signaling peptide ii from e. modified coli and a microorganism expressing a peptide fusion protein and a heterologous protein | |
ATE278708T1 (en) | CONOTOXIN PEPTIDE PVIIA | |
KR880009125A (en) | Pancreatic secretive trypsin inhibitors and variants thereof, methods thereof, expression vectors and recombinant hosts and pharmaceutical uses thereof produced by recombinant hosts | |
BR9306272A (en) | Peptide and pharmaceutical composition | |
RU93045577A (en) | MULTIPLE POLYPEPTIDES | |
RS49517B (en) | PEPTIDE p277 ANALOGS, AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM | |
DE69827262D1 (en) | PENAEIDINE: ANTIMICROBIAL PEPTIDES FROM CARBURATORS | |
FI893833A0 (en) | REKOMBINANT AKTIVATOR FOER NATURLIGA DOEDARCELLER. | |
UY25951A1 (en) | PURIFIED TUMOR NECROSIS FACTOR RECEPTOR POLYPEPTIDES (TYPE II) | |
ATE294816T1 (en) | NEW, PHYSIOLOGICALLY ACTIVE PEPTIDES AND THEIR USE. | |
ATE291033T1 (en) | THERAPEUTIC PEPTIDES | |
AR026068A1 (en) | MODIFIED AND PEPTIDOMIMETIC PEPTIDES FOR USE IN IMMUNOTHERAPY. | |
ATE25984T1 (en) | PHARMACOLOGICALLY ACTIVE PEPTIDES. | |
DK0946591T3 (en) | Cloned glucagon-like peptide-2 receptors | |
DE69928947D1 (en) | MORAXELLA CATARRHALIS BASB034 POLYPEPTIDES AND USES THEREOF | |
ES2063519T3 (en) | SYNTHETIC PEPTIDES THAT ANTAGONIZE NEUROQUININE A, ITS SALTS AND ITS PREPARATION PROCEDURES. | |
ATE46173T1 (en) | PHARMACOLOGICALLY ACTIVE PEPTIDES. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RDES | Application refused |
Effective date: 20110505 |